Table 4.
Remission | ||||||
---|---|---|---|---|---|---|
Yes | No | |||||
n | % | n | % | |||
Study | Treatment | Smoking status | 5 | 20.8 | 3 | 50.0 |
BUC-60 | Budesonide | Current smoker | ||||
Former smoker | 5 | 20.8 | 2 | 33.3 | ||
Never smoked | 14 | 58.3 | 1 | 16.7 | ||
Total | 24 | 100.0 | 6 | 100.0 | ||
Mesalazine | Smoking status | 3 | 37.5 | 8 | 47.1 | |
Current smoker | ||||||
Former smoker | 1 | 12.5 | 3 | 17.6 | ||
Never smoked | 4 | 50.0 | 6 | 35.3 | ||
Total | 8 | 100.0 | 17 | 100.0 | ||
Placebo | Smoking status | 2 | 14.3 | 10 | 43.5 | |
Current smoker | ||||||
Former smoker | 3 | 21.4 | 7 | 30.4 | ||
Never smoked | 9 | 64.3 | 6 | 26.1 | ||
Total | 14 | 100.0 | 23 | 100.0 | ||
BUC-63 | Budesonide | Smoking status | 37 | 39.8 | 4 | 28.6 |
Current smoker | ||||||
Former smoker | 29 | 31.2 | 8 | 57.1 | ||
Never smoked | 27 | 29.0 | 2 | 14.3 | ||
Total | 93 | 100.0 | 14 | 100.0 |
Current + former smokers vs non-smokers in the placebo group: odds ratio (OR) 0.21, 95% confidence interval (CI) 0.04–1.00, p = 0.04.
Current smokers vs non-smokers in the placebo group: OR 0.14, 95% CI 0.01–1.04, p = 0.05.